Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-039259
Filing Date
2022-12-22
Accepted
2022-12-22 21:35:30
Documents
1
Period of Report
2022-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2123
  Complete submission text file 0000899243-22-039259.txt   3828
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 FIELDSTONE DRIVE WINCHESTER MA 01890
Business Address 1 FIELDSTONE DRIVE WINCHESTER MA 01890 5083857367
SEARS SAMUEL P JR (Reporting) CIK: 0001238483 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13467 | Film No.: 221483240